Tags

Type your tag names separated by a space and hit enter

Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.
J Lipid Res. 2014 06; 55(6):1150-64.JL

Abstract

Cytochrome P450 (CYP)-dependent metabolites of arachidonic acid (AA) contribute to the regulation of cardiovascular function. CYP enzymes also accept EPA and DHA to yield more potent vasodilatory and potentially anti-arrhythmic metabolites, suggesting that the endogenous CYP-eicosanoid profile can be favorably shifted by dietary omega-3 fatty acids. To test this hypothesis, 20 healthy volunteers were treated with an EPA/DHA supplement and analyzed for concomitant changes in the circulatory and urinary levels of AA-, EPA-, and DHA-derived metabolites produced by the cyclooxygenase-, lipoxygenase (LOX)-, and CYP-dependent pathways. Raising the Omega-3 Index from about four to eight primarily resulted in a large increase of EPA-derived CYP-dependent epoxy-metabolites followed by increases of EPA- and DHA-derived LOX-dependent monohydroxy-metabolites including the precursors of the resolvin E and D families; resolvins themselves were not detected. The metabolite/precursor fatty acid ratios indicated that CYP epoxygenases metabolized EPA with an 8.6-fold higher efficiency and DHA with a 2.2-fold higher efficiency than AA. Effects on leukotriene, prostaglandin E, prostacyclin, and thromboxane formation remained rather weak. We propose that CYP-dependent epoxy-metabolites of EPA and DHA may function as mediators of the vasodilatory and cardioprotective effects of omega-3 fatty acids and could serve as biomarkers in clinical studies investigating the cardiovascular effects of EPA/DHA supplementation.

Authors+Show Affiliations

Max Delbrueck Center for Molecular Medicine, Berlin, Germany Experimental and Clinical Research Center (ECRC), Berlin, Germany.Max Delbrueck Center for Molecular Medicine, Berlin, Germany.Experimental and Clinical Research Center (ECRC), Berlin, Germany.Max Delbrueck Center for Molecular Medicine, Berlin, Germany.Humboldt University of Berlin, Berlin, Germany.Humboldt University of Berlin, Berlin, Germany.Omegametrix GmbH, Martinsried, Germany.Experimental and Clinical Research Center (ECRC), Berlin, Germany HELIOS Klinikum Berlin-Buch, Berlin, Germany.Experimental and Clinical Research Center (ECRC), Berlin, Germany.Lipidomix GmbH, Berlin, Germany.Experimental and Clinical Research Center (ECRC), Berlin, Germany.Experimental and Clinical Research Center (ECRC), Berlin, Germany.Max Delbrueck Center for Molecular Medicine, Berlin, Germany.

Pub Type(s)

Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24634501

Citation

Fischer, Robert, et al. "Dietary Omega-3 Fatty Acids Modulate the Eicosanoid Profile in Man Primarily Via the CYP-epoxygenase Pathway." Journal of Lipid Research, vol. 55, no. 6, 2014, pp. 1150-64.
Fischer R, Konkel A, Mehling H, et al. Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. J Lipid Res. 2014;55(6):1150-64.
Fischer, R., Konkel, A., Mehling, H., Blossey, K., Gapelyuk, A., Wessel, N., von Schacky, C., Dechend, R., Muller, D. N., Rothe, M., Luft, F. C., Weylandt, K., & Schunck, W. H. (2014). Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. Journal of Lipid Research, 55(6), 1150-64. https://doi.org/10.1194/jlr.M047357
Fischer R, et al. Dietary Omega-3 Fatty Acids Modulate the Eicosanoid Profile in Man Primarily Via the CYP-epoxygenase Pathway. J Lipid Res. 2014;55(6):1150-64. PubMed PMID: 24634501.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. AU - Fischer,Robert, AU - Konkel,Anne, AU - Mehling,Heidrun, AU - Blossey,Katrin, AU - Gapelyuk,Andrej, AU - Wessel,Niels, AU - von Schacky,Clemens, AU - Dechend,Ralf, AU - Muller,Dominik N, AU - Rothe,Michael, AU - Luft,Friedrich C, AU - Weylandt,Karsten, AU - Schunck,Wolf-Hagen, Y1 - 2014/03/16/ PY - 2014/01/20/received PY - 2014/3/18/entrez PY - 2014/3/19/pubmed PY - 2014/3/19/medline KW - cytochrome P450 KW - lipidomics KW - nutrition SP - 1150 EP - 64 JF - Journal of lipid research JO - J Lipid Res VL - 55 IS - 6 N2 - Cytochrome P450 (CYP)-dependent metabolites of arachidonic acid (AA) contribute to the regulation of cardiovascular function. CYP enzymes also accept EPA and DHA to yield more potent vasodilatory and potentially anti-arrhythmic metabolites, suggesting that the endogenous CYP-eicosanoid profile can be favorably shifted by dietary omega-3 fatty acids. To test this hypothesis, 20 healthy volunteers were treated with an EPA/DHA supplement and analyzed for concomitant changes in the circulatory and urinary levels of AA-, EPA-, and DHA-derived metabolites produced by the cyclooxygenase-, lipoxygenase (LOX)-, and CYP-dependent pathways. Raising the Omega-3 Index from about four to eight primarily resulted in a large increase of EPA-derived CYP-dependent epoxy-metabolites followed by increases of EPA- and DHA-derived LOX-dependent monohydroxy-metabolites including the precursors of the resolvin E and D families; resolvins themselves were not detected. The metabolite/precursor fatty acid ratios indicated that CYP epoxygenases metabolized EPA with an 8.6-fold higher efficiency and DHA with a 2.2-fold higher efficiency than AA. Effects on leukotriene, prostaglandin E, prostacyclin, and thromboxane formation remained rather weak. We propose that CYP-dependent epoxy-metabolites of EPA and DHA may function as mediators of the vasodilatory and cardioprotective effects of omega-3 fatty acids and could serve as biomarkers in clinical studies investigating the cardiovascular effects of EPA/DHA supplementation. SN - 1539-7262 UR - https://www.unboundmedicine.com/medline/citation/24634501/Dietary_omega_3_fatty_acids_modulate_the_eicosanoid_profile_in_man_primarily_via_the_CYP_epoxygenase_pathway_ L2 - http://www.jlr.org/cgi/pmidlookup?view=long&pmid=24634501 DB - PRIME DP - Unbound Medicine ER -